Standard BioTools (LAB)
NASDAQ:LAB
Holding LAB?
Track your performance easily

Standard BioTools (LAB) Financial Statements

437 Followers

Standard BioTools Financial Overview

Standard BioTools's market cap is currently ―. The company's EPS TTM is $-0.901; its P/E ratio is -2.25; Standard BioTools is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 37.20M$ 45.54M$ 28.19M$ 25.37M$ 27.67M
Gross Profit$ 14.91M$ 24.19M$ 10.78M$ 11.15M$ 13.60M
EBIT$ -45.66M$ -38.73M$ -18.84M$ -19.72M$ -15.61M
EBITDA$ -42.28M$ -33.54M$ -14.93M$ -16.74M$ -12.60M
Net Income Common Stockholders$ -45.72M$ -78.17M$ -19.78M$ -21.00M$ -17.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 394.71M$ 462.28M$ 114.89M$ 128.85M$ 142.30M
Total Assets$ 708.73M$ 777.67M$ 323.07M$ 339.29M$ 355.83M
Total Debt$ 90.55M$ 91.90M$ 98.21M$ 99.72M$ 101.39M
Net Debt$ -304.16M$ -370.38M$ -16.68M$ -29.13M$ -40.92M
Total Liabilities$ 198.47M$ 200.35M$ 159.87M$ 159.75M$ 157.96M
Stockholders Equity$ 510.26M$ 577.32M$ -148.05M$ -131.72M$ -113.39M
Cash Flow-
Free Cash Flow$ -40.99M$ -63.26M$ -14.14M$ -12.32M$ -10.17M
Operating Cash Flow$ -39.05M$ -62.48M$ -14.06M$ -11.41M$ -9.33M
Investing Cash Flow$ 50.26M$ 318.07M$ -13.12M$ -49.93M$ 40.13M
Financing Cash Flow$ -28.36M$ -19.73M$ -1.00M$ -1.16M$ -2.08M
Currency in USD

Standard BioTools Earnings and Revenue History

Standard BioTools Debt to Assets

Standard BioTools Cash Flow

Standard BioTools Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis